0000000000009047

AUTHOR

Sophia Heinrich

showing 2 related works from this author

High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma

2021

Abstract Background Hepatocellular carcinoma is one of the most lethal cancers worldwide. Novel prognostic and/or predictive biomarkers are urgently needed to improve patient management. Alpha‐fetoprotein (AFP) is a well‐established and widely used biomarker for hepatocellular carcinoma. However, diagnostic accuracy of static AFP values is limited and the clinical potential is a matter of ongoing scientific discussion. Objective We here evaluated the prognostic impact of pretreatment static and dynamic AFP variables on overall survival of hepatocellular carcinoma patients in a Western cohort. Methods Patients with confirmed hepatocellular carcinoma (n = 809) treated at the Johannes Gutenber…

Oncologymedicine.medical_specialtyalpha‐fetoproteinsurvival03 medical and health sciences0302 clinical medicineInternal medicinemedicineOverall survivalCarcinomaPredictive biomarkerbusiness.industryGastroenterologyhepatocellular carcinomamedicine.diseasedigestive system diseasesPatient managementOncology030220 oncology & carcinogenesisHepatocellular carcinomabiomarkerBiomarker (medicine)Original Article030211 gastroenterology & hepatologyHepatobiliaryprognosisAlpha-fetoproteinbusinessUnited European Gastroenterology Journal
researchProduct

Integrative genomic analyses identified 14-3-3 zeta as a potential molecular driver of sorafenib resistance in HCC patients

2021

14-3-3-ZETAbusiness.industryCancer researchMedicinebusinessSorafenib resistanceViszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Sektion Endoskopie der DGVS, Deutsche Gesellschaft für Allgemein und Viszeralchirurgie (DGAV)
researchProduct